Search Results: European Community (5)
-
The World Health Organization (WHO) has launched target product profiles to drive the rapid development of novel tuberculosis (TB) preventive treatment today. The target product profiles characterise the most important product attributes to be considered for developing the best suited TB prevention treatments in future.
One quarter of the global population is estimated to be infected with TB and are at greater risk of developing TB disease, especially those with weakened immunity. Treatment of T
Roles: Everyone: All Users
Regions: Canada , France , Italy , United Kingdom
Topics: Global Health
-
The fourth meeting of the Emergency Committee convened by the WHO Director-General under the International Health Regulations (IHR) (2005) regarding the coronavirus disease (COVID-19) took place on Friday, 31 July 2020 from 12:00 to 17:45
Geneva time (CEST).
Proceedings of the meeting
Members and advisors of the Emergency Committee were convened by vid
Roles: Everyone: All Users
Regions: United Kingdom
Topics: Coronavirus (COVID-19), Global Health, Science, Technology, and Innovation
-
- Seventy-five countries submit expressions of interest to COVAX Facility, joining up to 90 further countries which could be supported by the COVAX Advance Market Commitment (AMC)
- The COVAX Facility, and the AMC within it, is designed to guarantee rapid, fair and equitable access to COVID-19 vaccines for every country in the world, rich and poor, to make rapid progress towards slowing the pandemic
- Interest from governments represen
Roles: Everyone: All Users
Regions: Argentina, Canada , Norway , United Kingdom
Topics: Coronavirus (COVID-19), Global Health, Refugee and Humanitarian Assistance, Science, Technology, and Innovation
-
A special #EndTB Webinar organized by the World Health Organization (WHO) to provide key updates on recently released new WHO guidance on rapid diagnostics and drug-resistant TB treatment. The aim of the webinar is to facilitate better understanding of the guidance to enable its rapid uptake in countries by national programmes and other key stakeholders. This will translate to earlier access to quality diagnosis and treatment, and better outcomes for the millions affected by TB and drug-resistant TB.
Roles: Everyone: All Users
Regions: United Kingdom
Topics: Global Health, Science, Technology, and Innovation
-
Roles: Everyone: All Users
Regions: Canada , China, Singapore , United Kingdom
Topics: Coronavirus (COVID-19), Global Health, Science, Technology, and Innovation